Company Number: 15439589

Analysis Date: 2025-07-19 13:03 UTC

Financial Health Assessment for DASMAS LTD

---

1. Financial Health Score: C

Explanation:
DASMAS LTD, a micro private limited company in its first year of operation, shows very modest financial activity with minimal net assets and marginal profit. While it is not in distress, the financial "vital signs" indicate a fragile state typical of a startup phase. The company’s cash flow and equity base are minimal, so it is vulnerable to business shocks but currently stable.

---

2. Key Vital Signs

Metric	Value (£)	Interpretation
Turnover	22,361	Low revenue consistent with micro entity status and startup phase. Limited sales volume.
Profit or (Loss) for the period	11	Barely breaking even, indicating tight margins or initial investment phase.
Net Assets	600	Very low equity base; minimal buffer against liabilities.
Share Capital	600	Indicates initial funding level; no additional retained earnings.
Staff Costs	16,570	High proportion of turnover spent on staff, suggesting lean operations but pressure on profitability.
Cost of Materials	5,780	Moderate cost related to goods or services sold.
Average Number of Employees	1	Sole operator or very small team; aligns with micro entity profile.

Interpretation:
The company displays a "pulse" of a new business with low revenue and minimal reserves. Operating expenses, especially staff costs, consume most income, leaving negligible profit—a symptom of early-stage financial stress but not yet critical distress.

---

3. Diagnosis

DASMAS LTD is in the initial phase of business life, showing the typical symptoms of a startup: minimal turnover, almost break-even profit, and very low net assets. The company is solvent with positive equity, but the financial "immune system" is weak due to limited capital and revenue base. The director is also the sole significant controller and operator, which concentrates control but also risk.

Key observations:

• The company is operationally active and compliant with filing deadlines, indicating good governance.
• The freight transport industry (SIC 49410) often involves variable costs and tight margins, which may explain the high staff costs relative to turnover.
• The minimal net assets (equity) suggest limited capacity to absorb losses or fund growth internally.
• No debts or liabilities disclosed beyond current liabilities, which is positive for liquidity.
• The company’s financial "symptoms" do not indicate distress but rather a need for growth in sales and capital to strengthen financial resilience.

---

4. Recommendations

To improve financial wellness and avoid future liquidity or solvency issues, DASMAS LTD should consider the following actions:

• Increase Revenue Streams: Implement marketing and sales strategies to grow turnover beyond the current £22k. Scaling operations will improve profit margins and asset base.
• Cost Control: Review staff and material costs to enhance operational efficiency. Even at small scale, controlling overhead is vital.
• Capital Injection: Consider additional equity funding or loans to build a stronger capital buffer, providing a cushion for business fluctuations.
• Cash Flow Monitoring: Maintain healthy cash flow practices to ensure operational expenses are met without stress.
• Financial Planning: Develop a budget and cash flow forecast to anticipate funding needs and avoid liquidity crunches.
• Diversification: Explore expanding service offerings or client base within freight transport to reduce dependence on limited contracts.
• Professional Advice: Engage with accountants or business advisors to optimize tax, accounting, and financial management practices.

---

Medical Analogy Summary

DASMAS LTD's financial health resembles that of a newborn patient: vulnerable but stable, with a heartbeat just detectable (profit of £11). The company is not in "financial distress" yet, but it has minimal reserves ("low blood pressure") and needs nurturing through revenue growth and capital strengthening to build a robust financial immune system. Without careful management, the company risks "infection" from cash flow shortages or unexpected expenses.

---